1. Home
  2. AVY vs DGX Comparison

AVY vs DGX Comparison

Compare AVY & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVY
  • DGX
  • Stock Information
  • Founded
  • AVY 1935
  • DGX 1967
  • Country
  • AVY United States
  • DGX United States
  • Employees
  • AVY N/A
  • DGX N/A
  • Industry
  • AVY Containers/Packaging
  • DGX Medical Specialities
  • Sector
  • AVY Consumer Discretionary
  • DGX Health Care
  • Exchange
  • AVY Nasdaq
  • DGX Nasdaq
  • Market Cap
  • AVY 16.8B
  • DGX 17.5B
  • IPO Year
  • AVY N/A
  • DGX 1996
  • Fundamental
  • Price
  • AVY $188.15
  • DGX $152.77
  • Analyst Decision
  • AVY Buy
  • DGX Buy
  • Analyst Count
  • AVY 12
  • DGX 14
  • Target Price
  • AVY $242.72
  • DGX $168.14
  • AVG Volume (30 Days)
  • AVY 597.8K
  • DGX 872.4K
  • Earning Date
  • AVY 01-29-2025
  • DGX 01-30-2025
  • Dividend Yield
  • AVY 1.87%
  • DGX 1.96%
  • EPS Growth
  • AVY 40.44
  • DGX 11.56
  • EPS
  • AVY 8.33
  • DGX 7.44
  • Revenue
  • AVY $8,680,500,000.00
  • DGX $9,539,000,000.00
  • Revenue This Year
  • AVY $5.94
  • DGX $7.33
  • Revenue Next Year
  • AVY $4.86
  • DGX $8.70
  • P/E Ratio
  • AVY $22.58
  • DGX $20.59
  • Revenue Growth
  • AVY 4.84
  • DGX 2.60
  • 52 Week Low
  • AVY $185.73
  • DGX $123.04
  • 52 Week High
  • AVY $233.48
  • DGX $165.32
  • Technical
  • Relative Strength Index (RSI)
  • AVY 28.06
  • DGX 35.90
  • Support Level
  • AVY $185.73
  • DGX $152.18
  • Resistance Level
  • AVY $193.39
  • DGX $156.54
  • Average True Range (ATR)
  • AVY 3.60
  • DGX 2.95
  • MACD
  • AVY -1.41
  • DGX -1.10
  • Stochastic Oscillator
  • AVY 11.68
  • DGX 17.22

About AVY Avery Dennison Corporation

Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Share on Social Networks: